Genetic Testing for Specific Conditions
This study is looking at new ways to help people with certain health conditions get genetic testing. The conditions include genetic predisposition (an increased chance of developing a disease due to your genes), paraganglioma (a rare tumor), pheochromocytoma (a tumor of the adrenal gland), ALS (Lou Gehrig's disease), and Parkinson's disease. Researchers are testing if a "behavioral nudge" – a gentle reminder or suggestion – given to doctors or patients can increase the number of people who get genetic testing. The goal is to see if these nudges can make it easier for people to get genetic testing when the results could help guide their medical care. The study aims to enroll 1000 participants.
- Study design
- This is an interventional study, meaning participants will receive a specific intervention. It is a pragmatic randomized clinical trial, which means participants will be randomly assigned to different groups to compare the effectiveness of various nudges.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary outcome, the rate of genetic testing, will be measured at 3 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Katherine L Nathanson, MD · PRINCIPAL_INVESTIGATOR · University of Pennsylva
- Robert Schnoll, PhD · PRINCIPAL_INVESTIGATOR · University of Pennsylva
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Rate of Genetic Testing3 years
The number of patients seen by the total number of genetic tests conducted